Atrial fibrillation following oral sumatriptan administration

Devadathan, Sen; Gunning, Mark

doi:10.1016/j.ijcard.2004.11.039

Cited by 5 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Because of the risk of cardiovascular events, triptans are contraindicated in patients with myocardial infarction or angina pectoris . Triptans and NSAIDs may increase the incidence of atrial fibrillation (AF) , and migraine itself may induce AF .…”

Section: Introductionmentioning

confidence: 99%

Kampo extract goshuyuto for prevention of paroxysmal atrial fibrillation associated with migraine attack

Kato

Sakuma

et al. 2018

Traditional & Kampo Medicine

View full text Add to dashboard Cite

Case: Not only non-steroidal anti-inflammatory drugs (NSAIDs) but also triptans, called a 'magic bullet' against migraine attacks, increase the incidence of atrial fibrillation (AF). Additionally, the migraine attack itself may induce AF. A 66-year-old man visited hospital, complaining of palpitation after taking NSAIDs containing acetaminophen, ethenzamide and caffeine for a migraine attack. When pilsicainide hydrochloride hydrate was given, the AF was restored to sinus rhythm in 2 h. Outcome: Goshuyuto, a kampo formula used for headache, consists of four constituent drugs: Zizyphus fructus, Evodia fructus, Ginseng radix and Zingiber rhizome; these four crude drugs may induce multiple interactions. After taking goshuyuto combined with sodium valproate, no further migraine occurred for 3 months and no AF was observed. Conclusion: The kampo extract goshuyuto may be an option to prevent paroxysmal AF associated with migraine attack.

show abstract

Section: Introductionmentioning

confidence: 99%

Kampo extract goshuyuto for prevention of paroxysmal atrial fibrillation associated with migraine attack

Kato

Sakuma

et al. 2018

Traditional & Kampo Medicine

View full text Add to dashboard Cite

show abstract

Current awareness: Pharmacoepidemiology and drug safety

2006

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

In order to keep subscribers up‐to‐date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 20 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti‐infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non‐steroidal Anti‐inflammatory Agents; 7 CNS Agents; 8 Anti‐neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator‐Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti‐inflammatory Agents ‐ Steroidal; 19 Teratogens/fetal exposure; 20 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.

show abstract